Showing 391-400 of 4005 results for "".
Current and Emerging Roles of Immunotherapy and ADCs for Patients with Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
https://reachmd.com/programs/cme/current-and-emerging-roles-of-immunotherapy-and-adcs-for-patients-with-non-muscle-invasive-and-muscle-invasive-bladder-cancer/14553/Are you applying the latest data to your practice? Tune in for expert guidance on using ADCs and immunotherapy to treat your patients with mUC.Revolutionizing Breast Cancer Care: The Emerging Role of Liquid Biopsy Technologies
https://reachmd.com/programs/project-oncology/revolutionizing-breast-cancer-care-the-emerging-role-of-liquid-biopsy-technologies/26411/Liquid biopsies, especially ctDNA, may offer better sensitivity and specificity in breast cancer monitoring. Here’s a review of the latest research.Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
https://reachmd.com/programs/project-oncology/delivering-guideline-based-hepatocellular-carcinoma-care-with-an-interactive-tool/26320/Learn about a tool that can help clinicians implement the latest guidelines when diagnosing and treating patients with hepatocellular carcinoma.Beyond BCVA: Measuring Functional Vision in MacTel Type 2
https://reachmd.com/programs/cme/Beyond-BCVA-Measuring-Functional-Vision-in-MacTel-Type-2/35965/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.ASDS Highlights
https://reachmd.com/ma-issues-index/2022-nov-dec/asds-highlights/35226/Experts from around the world discussed the latest aesthetic treatments as well as what’s coming at the recent ASDS Annual Meeting.Updates on Sickle Cell Disease From ASH: A Hematologist’s Perspective
https://reachmd.com/programs/ash-action-center/updates-on-sickle-cell-disease-from-ash-a-hematologists-perspective/14199/Learn more about the latest advancements in the therapeutic landscape for patients with sickle cell disease.Improving CRC Screening Conversations in Primary Care
https://reachmd.com/programs/clinicians-roundtable/improving-crc-screening-conversations-in-primary-care/56455/Shared decision-making can be difficult to incorporate into already time-constrained primary care visits, especially when discussing colorectal cancer screening (CRC) options with patients. Join Dr. Natalia Usoltseva, a primary care provider at University of Washington Medicine, to hear how her pracEnhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
https://reachmd.com/programs/frontlines-multiple-sclerosis/enhancing-multiple-sclerosis-care-through-digital-cognitive-assessment/32668/Cognitive changes in multiple sclerosis often go unnoticed in clinical visits, despite having a profound impact on quality of life. However, digital cognitive assessment tools can help monitor brain function across key domains—like memory, attention, and motor planning—and predict real-world outcomeLeveraging Wearables for Pulmonary Arterial Hypertension Care
https://reachmd.com/programs/clinicians-roundtable/leveraging-wearables-for-pulmonary-arterial-hypertension-care/56329/Wearable devices and sensors are transforming how clinicians monitor and assess patients with pulmonary arterial hypertension between visits. Join Dr. Daniel Lachant as he explores how real-world activity data and heart rate metrics can enhance risk assessment, guide treatment decisions, and improveCurrent Landscape of MS Diagnosis/Prognosis
https://reachmd.com/programs/global-neurology-academy/current-landscape-ms-diagnosis-prognosis/7801/Dr. Gavin Giovannoni discusses the current landscape of multiple sclerosis diagnoses and prognosis, and continuity of care while at ECTRIMS 2015 in Barcelona, Spain. Click here to visit BartsMS Blog, an informative site Dr. Giovannoni has developed for people affected by multiple sclerosis. This int